---
title: Delpharm vs Lupin Limited
slug_a: delpharm
slug_b: lupin
site: cdmo
review_signal_gate: closed
canonical_path: /compare/delpharm/lupin
generated_by: BioBM Editorial AI
---

# Delpharm vs Lupin Limited

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Delpharm (delpharm) is listed for cdmo. Top-5 global CDMO with 18 production sites across Europe and North America, specializing in solid, semi-solid, non-sterile and sterile liquid dosage forms including prefilled syringes, nasal sprays, and injectables; capacity to produce over 300 million units annually.

Services: 14. Modalities: 2. Indications: 0. Locations: 36. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (36).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Lupin Limited (lupin) is listed for cdmo. Global pharmaceutical manufacturer with robust quality systems aligned to US FDA, UK MHRA, and EU GMP standards; operates diversified manufacturing across generics, complex formulations, and specialty segments with advanced automation and digital quality infrastructure.

Services: 11. Modalities: 3. Indications: 2. Locations: 5. Certifications: 9. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (11).

Review summary: Review summary withheld until site-level review gate opens.